EchoPrime, a video-based vision-language model, analyses echocardiogram footage and generates a written report of cardiac form and function. Its findings were published in Nature (volume 650, pages 970-977) in February 2026, under the title 'Comprehensive echocardiogram evaluation with view primed vision language AI.'
In a head-to-head comparison with five experienced physicians, each with more than a decade of practice, the system achieved higher accuracy across the board. DeepRare correctly identified the disease on its first suggestion 64.4 per cent of the time, compared to 54.6 per cent for the doctors. When given three suggestions instead of one, the AI system achieved diagnostic success in 79 per cent of cases versus 66 per cent for the human specialists.
OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation, The New York Times reports. The fresh funds come three months after the startup raised a $210 million round at a $3.5 billion valuation, a testament to the intense investor interest in industry-specific AI applications.
